"Bisphossy jaw": an adverse drug reaction with bisphosphonates

Deborah Layton; Anthony Cox

"Bisphossy jaw": an adverse drug reaction with bisphosphonates

Deborah Layton^*
, Anthony Cox

^*Corresponding author for this work

Aston Pharmacy School

Drug Safety Research Unit

Research output: Contribution to journal › Review article › peer-review

Abstract

Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm.

There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.

Original language	English
Pages (from-to)	331-332+338
Journal	Pharmaceutical Journal
Volume	283
Issue number	7571
Publication status	Published - 1 Sept 2009

Cite this

@article{c992a83761da43d6b46250245ecf5cf0,

title = "{"}Bisphossy jaw{"}: an adverse drug reaction with bisphosphonates",

abstract = "Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm. There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.",

author = "Deborah Layton and Anthony Cox",

year = "2009",

month = sep,

day = "1",

language = "English",

volume = "283",

pages = "331--332+338",

journal = "Pharmaceutical Journal",

issn = "0031-6873",

publisher = "Pharmaceutical Press",

number = "7571",

}

TY - JOUR

T1 - "Bisphossy jaw"

T2 - an adverse drug reaction with bisphosphonates

AU - Layton, Deborah

AU - Cox, Anthony

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm. There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.

AB - Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm. There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.

UR - http://www.pharmaceutical-journal.com/careers/career-feature/bisphossy-jaw-an-adverse-drug-reaction-with-bisphosphonates/10979417.article

UR - https://www.scopus.com/pages/publications/77955902714

M3 - Review article

SN - 0031-6873

VL - 283

SP - 331-332+338

JO - Pharmaceutical Journal

JF - Pharmaceutical Journal

IS - 7571

ER -

"Bisphossy jaw": an adverse drug reaction with bisphosphonates

Abstract

Other files and links

Fingerprint

Cite this